Johnson & Johnson : VP Of Investor Relations Mehrotra To Retire In January 2017

(RTTNews) - Johnson & Johnson (JNJ) announced that Louise Mehrotra, Vice President of Investor Relations for Johnson & Johnson, will retire in January 2017, after a transition period with her successor. Louise first joined the Johnson & Johnson Family of Companies in 1980, and has led Investor Relations for more than 10 years.

Joseph Wolk will replace Mehrotra as Vice President, Investor Relations, effective August 1. Wolk will continue to report to Dominic Caruso.

Wolk was previously Vice President, Group Finance for the Pharmaceuticals Group of Johnson & Johnson, where he provided finance leadership, supporting Worldwide Chairman, Pharmaceuticals Joaquin Duato, and Chief Scientific Officer Paul Stoffels, as a member of the Pharmaceuticals Group Operating Committee. Prior to that role, he held other finance leadership positions at Johnson & Johnson as Vice President of Finance for the Medical Devices Global Supply Chain, and as Chief Financial Officer of the North America Pharmaceuticals Group, responsible for Centocor Ortho Biotech Inc., as well as U.S. Pricing Strategy and Compliance. Wolk joined Johnson & Johnson in 1998 as a Finance Manager in the Ortho-McNeil Pharmaceutical organization.